Fidalab

Fidalab was paid $592K by Medicaid between Apr 2020 and Mar 2023, across 17 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 85% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Washington

Rank by total paid#26 of 76

Median peer was paid$90K

This provider vs. median6.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	6,353	$225K
2021	17,879	$271K
2022	10,793	$88K
2023	1,207	$8K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	85%	16,561	7,495	$502K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	5.0%	851	626	$30K
87481		2.1%	830	605	$12K
87150		1.6%	591	426	$9K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	1.2%	9,621	3,972	$7K
87529		<1%	822	601	$5K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	813	604	$3K
87653		<1%	819	606	$3K
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	<1%	351	150	$3K
87496		<1%	814	603	$3K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	802	592	$3K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	803	592	$3K

5 more codes

87640		<1%	814	$2K
87641		<1%	590	$2K
87511		<1%	510	$2K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	505	$2K
87500		<1%	135	$315.36

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialFENG, QINGHUA (CHIEF OF SCIENTIFIC OFFICER)